{"transactions":[{"id":2873072,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-02-09T21:14:20.000Z","date":"2020-12-31","kind":"gift","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting person gifted shares to the Robin Drive, LLC (the \"Trust\"), of which his wife is Trustee, on December 31, 2020.  Reporting person disclaims all beneficial ownership of the shares held by the Trust."}],"balance_after":4632,"source":{"system":"sec-edgar","filing":"0001127602-21-004675","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221004675/form5.xml","form_type":"5"}},{"id":2873071,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-02-09T21:14:20.000Z","date":"2020-12-31","kind":"gift","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Robin Drive, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting person gifted shares to the Robin Drive, LLC (the \"Trust\"), of which his wife is Trustee, on December 31, 2020.  Reporting person disclaims all beneficial ownership of the shares held by the Trust."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001127602-21-004675","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221004675/form5.xml","form_type":"5"}},{"id":3121178,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-06-05T21:19:11.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":890,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20632,"source":{"system":"sec-edgar","filing":"0001127602-20-019029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220019029/form4.xml","form_type":"4"}},{"id":3483323,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-06-20T21:52:52.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":1155,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19742,"source":{"system":"sec-edgar","filing":"0001127602-19-022422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219022422/form4.xml","form_type":"4"}},{"id":3589188,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-19T20:08:36.000Z","date":"2019-03-18","kind":"exercise","acquired":false,"shares":6114,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 5,975 shares at an exercise price of $53.43 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC Rule 16(b)-3(d)."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F2","text":"This option was previously reported as covering 5,975 shares at an exercise price of $53.43 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was previously reported as covering 5,975 shares at an exercise price of $53.43 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This option was previously reported as covering 5,975 shares at an exercise price of $53.43 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":53.43,"exercise_date":"2010-06-03","expiration_date":"2019-06-02","underlying":"Common Stock","underlying_shares":6114},"source":{"system":"sec-edgar","filing":"0001127602-19-012198","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219012198/form4.xml","form_type":"4"}},{"id":3589187,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-19T20:08:36.000Z","date":"2019-03-18","kind":"sale","acquired":false,"shares":6114,"price":328.55,"value":2008754.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":18587,"source":{"system":"sec-edgar","filing":"0001127602-19-012198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219012198/form4.xml","form_type":"4"}},{"id":3589186,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-19T20:08:36.000Z","date":"2019-03-18","kind":"exercise","acquired":true,"shares":6114,"price":52.22,"value":319273.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F2","text":"This option was previously reported as covering 5,975 shares at an exercise price of $53.43 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was previously reported as covering 5,975 shares at an exercise price of $53.43 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."}],"balance_after":24701,"source":{"system":"sec-edgar","filing":"0001127602-19-012198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219012198/form4.xml","form_type":"4"}},{"id":3894741,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-06-14T21:33:50.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":880,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18587,"source":{"system":"sec-edgar","filing":"0001127602-18-020966","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218020966/form4.xml","form_type":"4"}},{"id":4102397,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-10T22:28:35.000Z","date":"2018-01-09","kind":"exercise","acquired":false,"shares":5832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 5,700 shares at an exercise price of $59.17 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F2","text":"This option was previously reported as covering 5,700 shares at an exercise price of $59.17 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"This option was previously reported as covering 5,700 shares at an exercise price of $59.17 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":57.83,"exercise_date":"2009-06-19","expiration_date":"2018-06-18","underlying":"Common Stock","underlying_shares":5832},"source":{"system":"sec-edgar","filing":"0001127602-18-001563","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218001563/form4.xml","form_type":"4"}},{"id":4102396,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-01-10T22:28:35.000Z","date":"2018-01-09","kind":"sale","acquired":false,"shares":5832,"price":329.65,"value":1922518.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":17707,"source":{"system":"sec-edgar","filing":"0001127602-18-001563","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218001563/form4.xml","form_type":"4"}},{"id":4102395,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-01-10T22:28:35.000Z","date":"2018-01-09","kind":"exercise","acquired":true,"shares":5832,"price":57.83,"value":337264.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":23539,"source":{"system":"sec-edgar","filing":"0001127602-18-001563","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218001563/form4.xml","form_type":"4"}},{"id":4287712,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-06-09T21:50:56.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":1055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On 6/8/16 an RSU was awarded for 1,060 shares.  This award was adjusted to 1,084 shares pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."}],"balance_after":17707,"source":{"system":"sec-edgar","filing":"0001127602-17-021098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217021098/form4.xml","form_type":"4"}},{"id":4494406,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-10T21:15:29.000Z","date":"2017-01-09","kind":"exercise","acquired":false,"shares":5450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc."}],"balance_after":0,"derivative":{"exercise_price":52.22,"expiration_date":"2017-05-30","underlying":"Common Stock","underlying_shares":5450},"source":{"system":"sec-edgar","filing":"0001127602-17-001434","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217001434/form4.xml","form_type":"4"}},{"id":4494405,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-01-10T21:15:29.000Z","date":"2017-01-09","kind":"sale","acquired":false,"shares":5450,"price":295.39,"value":1609875.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":16628,"source":{"system":"sec-edgar","filing":"0001127602-17-001434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217001434/form4.xml","form_type":"4"}},{"id":4494404,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":142909,"kind":"person","name":"PANGIA ROBERT W","position":1,"cik":"0001236188","reported_name":"PANGIA ROBERT W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-01-10T21:15:29.000Z","date":"2017-01-09","kind":"exercise","acquired":true,"shares":5450,"price":52.22,"value":284599.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":22078,"source":{"system":"sec-edgar","filing":"0001127602-17-001434","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217001434/form4.xml","form_type":"4"}}]}